Browse All

Current Filters

CLEAR FILTER x

TITLE

Reduced Cerebrospinal Fluid Biomarkers (Neurofilament Light Chain, B Cells, T Cells) and Improved Clinical/Imaging Assessments of Disease Activity Are Sustained After 5 Years of Ocrelizumab Treatment: Long-term Extension Results from OBOE